US physicians’ views on genAI are shifting: While doctors’ positive stance on genAI presents a massive opportunity for vendors and patients alike, their outlook comes with a catch—the tech has to be vetted. AI developers, take note.

Most patients around the world lack trust in their healthcare system: They also feel self-empowered to take health into their own hands—a dangerous combination for healthcare providers, marketers, and even the media.

UnitedHealth facing $1.6B cyberattack hit this year: While the impact of the Change cyberattack has been bad for US physicians’ business, UnitedHealth has emerged relatively unscathed. Here’s why the worst could still be to come for the healthcare titan.

Lilly’s GLP-1 Zepbound found to reduce sleep apnea: Coming amid healthcare’s broader GLP-1 craze, we take a look at the opportunities these new clinical trial findings present and what it means for drug manufacturers.

The feds are watching how digital health companies use patient data: Two more telehealth entities were penalized for using consumer data for advertising. Here’s what it all means for health tech firms and marketers.

Kaiser rolls out Food Is Medicine Center of Excellence: The launch comes amid a frenzy of activity in the Food as Medicine movement. We explore the opportunities abound for providers and insurers alike.

Medicaid redeterminations see 20M disenrolled: The impact on patients has been dire. We uncover why we don’t expect providers to get off scot-free.

On today's podcast episode (part 1), we discuss why consumers are using GenAI to look up health information, how physicians feel about it, and how this stacks up against other health-related internet searches. Tune in to the discussion with our analyst Rajiv Leventhal.

On today's podcast episode (part 2), we discuss how doctors are using GenAI to deliver healthcare, how patients feel about it, and why you may climb into a large AI-driven box for your next primary care visit. Tune in to the discussion with our analyst Rajiv Leventhal.

US physicians continue to lose their independence: Nearly 4 in 5 are now employed by a health system or corporate entity. This ongoing trend may negatively affect healthcare competition in local markets as well as patient care.

Many younger consumers will ask about new medications: Their thirst for knowledge is a big opportunity for pharma marketers.

US drug shortages hit record high: While HHS issued recommendations to address the shortages, they’re not enough. We explore what needs to change.

How are healthcare orgs advancing on health equity? They’re making progress, but health disparities are still far too prevalent in the US. We explore what needs to improve.

Medical claim denials are spiking: Provider-payer battles over denied claims result in a lot of wasted money. It may get uglier in 2024, particularly in the Medicare Advantage market.

80% of docs lost revenues from Change Healthcare cyberattack: Meanwhile, strong cybersecurity has generated 4X financial performance for some organizations. We detail how protecting against cyberattacks can drive financial returns.

Pharma marketers adapted to doctors’ content preferences last year: Many doctors don’t want to meet with pharma sales reps in person. We explore which digital channels got the biggest utilization boosts in 2023.

Seniors aren’t comfortable with all digital health tools: They prefer human help for managing health-related needs. But they must be able to trust the people who are supporting them.

More digital health deals, lower check sizes in Q1: Healthcare AI startups are a hot investor item right now. Other sub-sectors of digital health? Not as much.

Meta makes the Quest 3 more like Apple’s Vision Pro: It launches an experimental app with spatial computing features. The Quest’s relative affordability is Meta’s advantage.

Consumer access to OTC birth control pill improves: CVS Caremark’s decision to cover Perrigo’s Opill at no cost for many health plan sponsors comes at a critical time.